In Reply: The benefits and harms of breast cancer screening

The Lancet

Volumn 381, Issue 9869, 2013, Pages 800-

  Autier, Philippe ^a   Boniol, Mathieu ^a   Boyle, Peter ^a  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; HUMAN; LETTER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED KINGDOM; EARLY CANCER DIAGNOSIS; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; MASS SCREENING; METHODOLOGY; NOTE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING;

EID: 84879487175     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60620-0     Document Type: Letter

References (5)

1. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
2. Autier P, Boniol M, LaVecchia C, et al. Disparities in breast cancer mortality trends between thirty European countries: retrospective trend analysis of WHO mortality database. BMJ 2010; 341: c3620.
3. International Agency for Research on Cancer. IARC/WHO handbooks of cancer prevention, volume 7: Breast Cancer Screening. Lyon: IARC, 2002.
4. Autier P, Boniol M, Middleton R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011; 22: 1726-35.
5. Autier P, Boniol M. The incidence of advanced breast cancer in the West Midlands, United Kingdom. Eur J Cancer Prev 2012; 21: 217-21.